Survival for liver cancer

Survival depends on different factors. No one can tell you exactly how long you will live.

Doctors usually work out the outlook for a certain disease by looking at large groups of people. Primary liver cancer Open a glossary item is less common. So survival is harder to estimate than for other, more common cancers.

Some of the statistics have to be based on a small number of people. Remember, they can't tell you what will happen in your individual case.

Your doctor can give you more information about your own outlook (prognosis).

You can also talk about this to the Cancer Research UK nurses on freephone 0808 800 4040, from 9am to 5pm, Monday to Friday.

The information on this page is for primary liver cancer. Primary liver cancer is different to cancer that spreads to your liver from somewhere else in your body. This is called secondary liver cancer or liver metastases.

About these statistics

The terms 1 year, 4 year or 5 year survival don't mean that you will only live for 1 or 4 or 5 years.

Organisations such as NHS Digital and researchers collect information. They watch what happens to people with cancer in the years after their diagnosis. So for example, 5 years is a common time point to measure survival. But some people live much longer than this.

5 year survival is the number of people who have not died from their cancer within 5 years after diagnosis.

These figures include anyone age 15 or above with different types of primary liver cancer including: 

  • hepatocellular carcinoma
  • intrahepatic bile duct carcinoma
  • angiosarcoma
  • hepatoblastoma

We have information about survival for children age 14 and under with hepatoblastoma on our children's statistics page.

Survival by stage

There are no UK-wide statistics available for liver cancer by stage. Survival statistics are available for each stage of primary liver cancer in England. These figures are for people diagnosed between 2015 and 2019. 

These are 4 year survival statistics, as 5 year survival statistics are not available. 

Stage 1

Almost 50 out of 100 people (almost 50%) with stage 1 liver cancer will survive their cancer for 4 years or more after they're diagnosed. 

Stage 2 

Around 35 out of 100 people (around 35%) with stage 2 liver cancer will survive their cancer for 4 years or more after they're diagnosed. 

Stage 3 

Around 10 out of 100 people (around 10%) with stage 3 liver cancer will survive their cancer for 4 years or more after they're diagnosed. 

Stage 4 

Almost 5 out of 100 people (almost 5%) with stage 4 liver cancer will survive their cancer for 4 years or more after they're diagnosed.

Survival for all stages of liver cancer

There are no UK-wide statistics available for the survival for all stages of liver cancer. Survival statistics are available for people with primary liver cancer in England. These figures are for people diagnosed in England between 2016 and 2020.

For people diagnosed with liver cancer in England:

  • 40 out of 100 people (40%) will survive their cancer for 1 year or more after diagnosis
  • almost 15 out of 100 people (almost 15%) will survive their cancer for 5 years or more after they are diagnosed

What affects survival?

Your outlook is affected by the treatment you have.

Treatment decisions depend on the size of the cancer and whether it has spread. It also depends on the health of your liver tissue that is not affected by the cancer, for example if you have liver cirrhosis. 

Your general fitness and other health conditions also affect survival. Health conditions could affect the treatments you can have. And good general fitness might help you cope better with your cancer and treatment.

More statistics

For more in-depth information about survival and liver cancer, go to our Cancer Statistics section.

  • Cancer survival in England, cancers diagnosed 2016 to 2020, followed up to 2021
    NHS England

  • British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults
    A Suddle and others
    Gut, 2024. Volume 0. Pages 1-34

  • Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow up
    A Vogel and others
    Annals of Oncology, 2025

Last reviewed: 
01 Apr 2025
Next review due: 
31 Mar 2028

Related links